$PG

Procter & Gamble’s Financial Results Top Wall Street Estimates

Procter & Gamble (PG) reported Q3 earnings per share of $2, beating estimates of $1.88, and revenue of $23.3B, exceeding expectations of $22.8B. Sales grew 4% year-over-year, driven by demand for laundry and home care products. The company expects fiscal 2027 EPS of $6.89-$7.11 and sales growth of 2-4%. PG stock has risen 3% in the past year.

Original reporting
Published Oct 22, 2026, 1:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 2:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Procter & Gamble’s Financial Results Top Wall Street Estimates — source image
Decision brief

The 30-second read

$PGBullishHigh
01

Why it matters

The earnings beat reinforces confidence in the company's pricing power, but modest guidance tempers enthusiasm.

02

Market read

Strong earnings beat provides a short‑term catalyst for PG and may influence broader consumer‑staples sentiment.

03

What to watch

Rising promotional pricing could compress margins; low‑income consumer pressure may weigh on future volume growth.

Relevance 9/10Novelty 9/10Timing: today

Background

Procter & Gamble is a leading consumer‑goods company; its earnings are closely watched for consumer spending trends.

Company-level read

Ticker impact

$PGBullishHigh confidence
Context

Procter & Gamble reported Q3 earnings that beat EPS and revenue estimates and provided FY2027 guidance.

Expected impact

likely modest upside as investors price in the earnings beat and FY guidance

Evidence & confidence

The beat was 2.0% above EPS consensus and revenue was $0.5B above estimates; guidance is in line with expectations, supporting a positive but limited move.

Market effects

Consumer staples may see a slight lift as a bellwether consumer goods company posts a beat.

U.S. market could see modest gains in the consumer discretionary and staples indices.

Limited; primarily affects U.S. equities and global consumer staples exposure.

Counterpoint

Guidance is modest and may signal slower growth, suggesting a potential pullback after the initial rally.

Key entities

  • Procter & Gamble

    Consumer goods conglomerate reporting Q3 results.

Related articles

$PGHighAI 8/10

P&G’s Q1 Results Draw Price-Target Hikes As Analysts Cite Stronger Underlying Performance

Procter & Gamble (P&G) reported Q1 adjusted earnings of $2.00 per share, beating estimates, with revenue of $23.28 billion also topping forecasts. The company maintained its fiscal 2027 organic sales and EPS growth outlooks but raised its all-in sales growth outlook to 2%-4% due to its acquisition of Thorne. P&G also increased its estimated fiscal 2027 after-tax commodity cost headwind to $1.4 billion.

$PGHighAI 8/10

TD Cowen raises Procter & Gamble stock price target on turnaround progress

TD Cowen raised its price target for Procter & Gamble (NYSE:PG) to $166 from $150, citing strong Q1 performance and potential for full-year guidance. The firm maintained a Hold rating due to uncertainty about U.S. momentum. PG reported Q1 earnings of $2.00 per share on $23.28B revenue, exceeding estimates. Morgan Stanley also raised its target to $185, highlighting profit upside.

$PGHighAI 8/10

PG Q1 Earnings Call Highlights Growth Amid Rising Cost Pressures

Procter & Gamble (PG) reported Q1 fiscal 2027 earnings of $2.00 per share, beating estimates, with revenues up 4% to $23.28 billion. Management highlighted organic growth but cautioned about rising commodity costs. PG maintained its full-year outlook, expecting 1-3% organic sales growth and 0-3% core earnings growth. Higher costs are pressuring margins, with a projected $1.9 billion after-tax headwind.

$PGHighAI 8/10

Procter & Gamble Co (PG) (Q1 2027) Earnings Call Highlights: Broad-Based Organic Growth

Procter & Gamble (PG) reported Q1 2027 earnings with organic sales growth of 4% and volume growth of 2%. Margins declined due to higher costs, with a $1.4B after-tax impact expected for fiscal '27. Guidance suggests a deceleration in organic sales growth to 3% in the first half. CFO Andre Schulten attributed margin improvements to productivity gains and restructuring. Challenges include commodity cost headwinds, foreign exchange, and higher interest expenses.

$PGHighAI 9/10

Procter & Gamble Co (PG) (Q1 2027) Earnings Call Highlights: Bro

Procter & Gamble (PG) reported Q1 2027 earnings with organic sales up 4.0% and core EPS at $2.00. All 10 product categories and six regions grew. Margins declined due to higher costs. FY27 guidance: 1-3% sales growth, 0-3% core EPS growth, and $15 billion in cash returns. Commodity and FX headwinds are expected to impact earnings.